drugset / Trial / NCT01606202

A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury

NCT01606202

Phase 3 Completed 116 enrolled Jazz Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A study to investigate the effects of sublingual cannabis based medicine extracts on neuropathic pain associated with spinal cord injury.

Timeline

Start
2002-07
Primary completion
2005-01
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Nabiximols Other / unclassified 2.5 mg Other
Subject Nabiximols Other / unclassified 2.7 mg Other

Indications

No indication recorded.